Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Rua Alfredo Allen, 208 4200-135 Porto, Portugal
Phone: +351 226 074 900
Email: info@i3s.up.pt
Immunology, Cancer & Glycomedicine
WHAT WE DO
Our Lab
Our group works at the interface of immunology, cancer and glycobiology, using a combination of in vitro, ex vivo and in vivo approaches.
Publications
The group’s research has been published in a number of high-impact publications over the years.
Research Topics
The group’s research explores several topics related to the impact of glycans on inflammation, autoimmunity and cancer.
OUR RESEARCH
OUR GROUP MAIN LINES OF RESEARCH:
Immune response
The exploitation of the cellular and molecular mechanisms by which glycans contribute to amplify immune response in chronic inflammation and autoimmunity.
OUR GROUP MAIN LINES OF RESEARCH:
Cancer glycosignatures
The investigation of how cancer-specific glycosignatures regulate the immunological networks in cancer.
HIGHLIGHTS
New ICG Article published in Cancer Immunology Research on T cell glycosylation in colorectal cancer
In our most recent publication in Cancer Immunology Research, we describe how T cell glycosylation mediates T cell exhaustion in colorectal cancer and how engineering of the T cell glycome can boost the anti-tumor activity of CD8+ and CAR-T cells.
Eduarda Gomes awarded with a FEBS Fellowship for Secondment in Germany
Eduarda Leite-Gomes, a PhD Student from Pinho’s Lab, has recently been awarded with a short-term fellowship from the Federation of European Biochemical Societies.
ICG members awarded at the NEDAI 2025 XI National Congress
Pedro Cabral and Ana Campar have recently been awarded by NEDAI (Núcleo de Estudos de Doenças Auto-Imunes) at its XI National Congress, which also marked the XXX Annual Meeting of Autoimmunity in Portugal. Each was distinguished by their pioneering work in lupus nephritis and idiopathic inflammatory myopathies, respectively.